CVRx, Inc. (CVRX) has a MoatMap StockRank of 9/100 based on Quality (33/100), Value (37/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL. CVRx is a medical device company commercializing neuromodulation systems. Despite an innovative product, it is currently unprofitable with high sales and marketing expenses, failing our requirement for positive owner earnings.
CVRx, Inc. is a medical device company focused on developing and commercializing its proprietary Barostim™ neuromodulation technology to treat cardiovascular diseases like heart failure and hypertension. Its unique, FDA-approved implantable device offers a novel therapeutic option for patients with advanced heart failure who remain symptomatic despite conventional treatments, establishing a significant market niche.
| Price | $5.20 |
| Market Cap | $149M |
| P/E (Forward) | -3.10 |
| Price/Book | 5.34 |
| Return on Equity | -107.0% |
| Return on Invested Capital | -51.9% |
| Debt/Equity | 204.04 |
| Gross Margin | 86.2% |
| Operating Margin | -82.3% |
| Revenue Growth | 19.6% |
| Free Cash Flow | $-23M |
CVRx, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).